The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast Cancer Screening Recommendations

Getty Images


May 1, 2024 — The American College of Radiology (ACR) has issued a statement on the newly released Final USPSTF Breast Cancer Screening Recommendations. The final United States Preventive Services Task Force (USPSTFBreast Cancer Screening Recommendations, while an improvement over previous guidance, do not go far enough to save more women’s lives.

The American College of Radiology will continue to urge the USPSTF to recommend all women have a breast cancer risk assessment by age 25 (as called for in ACR’s Breast Cancer Screening guidelines for high-risk women) and that women at average risk for breast cancer receive an annual mammography screening starting at age 40. Women at higher risk for breast cancer should talk to their doctor about starting screening prior to age 40 and additional screening methods.

The USPSTF, American College of Radiology, American Cancer Society, Society of Breast Imaging and others all agree that the most lives are saved with this annual approach. The ACR and SBI maintain their commitment to promote the value of annual screenings with mammography as stated in their joint average-risk guidelines. Medical experts must clear the confusion caused by differing recommendations.

Mounting evidence shows that Black and other minority women, Jewish women, and others develop and die from breast cancer prior to age 50 — or even age 40 — more often than white women. As our 2021 guidelines for average-risk women and our 2023 guidelines for high-risk women make clear, potentially giving cancer another year to advance may particularly impact these women.

Involving factors such as sex assigned at birth, hormone use and surgical history place transgender persons at increased risk for breast cancer. Biological females transitioning to male who do not undergo mastectomy remain at their previous risk for breast cancer and should continue to be screened as such. 

As outlined in current (2021) ACR/SBI recommendations for average-risk women, due to hormone use, biological males transitioning to female are at increased risk for breast cancer compared to other males and should speak with their doctor about their breast cancer risk.

ACR and SBI also recommend that women continue screening past age 74, unless severe comorbidities limit life expectancy. 

For more information: www.acr.org

Related content:

Leading Organizations and Breast Imaging Experts Weigh in on New Task Force Screening Recommendations, Impact on Health Equity and Women’s Health

Leading Organizations and Breast Imaging Experts Weigh in on New Task Force Screening Recommendations, Impact on Health Equity and Women’s Health


Related Content

Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Flat Panel Displays

July 17, 2024 — LG Electronics (LG) is accelerating its B2B medical device business, expanding its lineup of diagnostic ...

Time July 17, 2024
arrow
Feature | Imaging Technology News - ITN

Be sure to check out the latest digital edition of Imaging Technology News (ITN), featuring the Mobile C-arm Systems ...

Time July 11, 2024
arrow
News | Artificial Intelligence

July 9, 2024 — Lunit, a provider of Artificial Intelligence (AI)-powered solutions for cancer diagnostics and ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
Subscribe Now